Picture of Biotest AG logo

BIO3 Biotest AG Cashflow Statement

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Annual cashflow statement for Biotest AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6-1.3-30-62.7-31.7
Depreciation
Non-Cash Items16.51.12517.515.7
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-85.2-65.1-41.348-60.3
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-50-33.6-16.733.9-40.5
Capital Expenditures-54.6-34.1-27-18.2-29.3
Purchase of Fixed Assets
Other Investing Cash Flow Items25526.112.4-5.2-7.7
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities201-8-14.6-23.4-37
Financing Cash Flow Items-15.22.70.13.6-3.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-11140.54222.689.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash39.6-1.110.533.112.1